Category Archives: Cancer

Multispectral Optoacoustic Tomography (MSOT) can now more reliably detect early stages of inflammation

GERMANY, Mar-30-2017 — /EPR HEALTHCARE NEWS/ — Ulcerative colitis and Crohn’s disease are the most common inflammatory bowel diseases (IBD). Globally, more than 4 million people suffer from recurring inflammation of the intestinal mucosa. To date, non-invasive methods have not been able to detect these forms of IBD reliably. Researchers at the University Hospital Erlangen (Germany) have now shown for the first time how Multispectral Optoacoustic Tomography (MSOT) can more reliably detect early stages of inflammation when compared with other non-invasive diagnostic methods. These results have recently been published in the New England Journal of Medicine.

Evaluating the inflammatory activity of the intestines early and accurately helps to prevent complications associated with IBD and guide an optimal therapy regime. Currently, doctors frequently rely on an invasive endoscopy procedure to assess the intestinal mucosa of patients with IBD. Additionally, non-invasive imaging methods are increasingly used in the clinic. For example, ultrasound allows clinicians to examine the structure, thickness and blood perfusion of the intestinal wall with changes in perfusion patterns indicating an onset of inflammation.

“With the MSOT procedure, we additionally use laser light, by which we can detect inflammation earlier than previously possible with ultrasound”, explains Prof. Dr. Maximilian Waldner, Professor at the University Hospital Erlangen. “The earlier we detect signs of an upcoming flare – i.e., a change in blood content – the quicker we can react and start a preventive treatment”. The MSOT technology was developed by iThera Medical in Munich, and was first used on IBD patients last year.

The researchers of the University Hospital Erlangen have recently published their results in the renowned New England Journal of Medicine. “We examined 108 patients with Crohn’s disease using the MSOT technology and compared the results to established non-invasive diagnostic procedures as well as endoscopy and histology”, says Prof. Waldner. “We were able to demonstrate that hemoglobin values in the tissue measured with MSOT indicate very accurately the inflammatory activity in the intestines. The method appears to be superior to other non-invasive procedures, as MSOT for the first time was able to detect even low levels of inflammation without having to perform endoscopy”.

Dr. Ferdinand Knieling, a physician at the University Hospital Erlangen, adds: “We are hoping that this principle can be applied to many applications and, in particular, also be used to enable safe evaluations of children and adolescents. With this new examination method, many of the currently invasive procedures might become obsolete.”

In optoacoustic imaging, the physician scans the intestines transabdominally through the skin, applying pulsed laser light in the near-infrared region. The energy of the light absorbed in tissue is converted into acoustic signals which are then acquired by an ultrasound detector. Christian Wiest, CEO of iThera Medical, comments: “MSOT is a new diagnostic imaging modality that can detect changes in tissue composition associated with a variety of diseases, without the use of contrast agents. The technology has already been applied in other clinical feasibility studies, e.g. for the detection of melanoma metastasis in sentinel lymph nodes or for the assessment of suspicious breast lesions”.

The results of the IBD study at the University Hospital Erlangen were published on March 30th 2017 in the New England Journal of Medicine (Volume 376, Issue 13, pg.1292-1294).

SOURCE: EuropaWire

EMS Healthcare’s recent work supporting better healthcare, closer to home

The prospect for major investment in new healthcare estates looks slim as the strategy to bring care closer to people’s homes becomes reality. Keith Austin, managing partner at EMS-Healthcare has looked at how the switch to community care is raising standards nationwide:

“Private Finance 2, which sets out a new approach to financing the building and maintenance of public infrastructure, will be used to build the next generation of hospitals. But despite its announcement at the end of last year there has been little movement to invest in new healthcare estates.

“The delay isn’t just about money or red tape; there is the wider strategy to consider of moving away from care delivered in hospitals to providing care closer to people’s homes.”

Keith continued, with how EMS Healthcare in particular helps address the costs involved with this kind of shift in patient care: “The scale of investment necessary to meet this ideal is much smaller than that required for developing new large scale hospital sites. But this isn’t the only benefit. We have been working with numerous private and public sector organisations to facilitate care in the community via medical trailer solutions and have been inspired by what has been delivered and the warm reception from patients and staff alike… To say the benefits can be life changing is not an overstatement.”

One stand out project for EMS Healthcare has been to fit out and supply Clatterbridge Cancer Centre with a state-of-the-art mobile chemotherapy facility. Since the beginning of the year the medical trailer has been improving patient care by making treatment as accessible and easy as possible, serving around 25 people daily from the Chester area in a Tesco car park.

“Perhaps an unlikely site for life-saving treatment, but the feedback from patients has been overwhelmingly positive. The bespoke medical trailer houses six chemotherapy stations with preparation, reception and waiting areas. Patients feel a real sense of community and ownership while attending the clinic and the environment has been described as ‘warm and cosy’ with a ‘more jovial atmosphere’.”

Other initiatives that EMS Healthcare have been involved in include a medical trailer eye clinic which helped medical consultants save the sight of thousands of patients across the East Coast of the UK, while saving them a trip of up to 84 miles for treatment. A temporary renal dialysis medical trailer unit has also saved patients in North Wales hours of travel every week, helping to improve their quality of life.

Thousands of patients across the UK are making long journeys to receive specialist treatment. These unique facilities provide a solution to help reduce the cost, burden and strain of travelling while delivering first class care. Waiting time is minimal too, making the experience less tiring, and a more familiar location helps put patients at ease.

The evidence is clear on why healthcare providers are taking their care closer to people’s homes. This patient-centric approach is set to continue and Keith – and EMS Healthcare – are proud to be part of it.

Via EPR Network
More Healthcare press releases

Innovative Drug Discovery Business, Biosortia Pharmaceuticals, Lands Two Health Care Veterans

Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead early stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named President and CEO in November 2012 and has quickly identified other key executives, including Dr. Guy Carter, former Natural Product head at Wyeth Pharmaceuticals, as his Chief Science Officer. In conjunction, other collaboration partners have joined the team, including NOAA (National Oceanic and Atmospheric Administration), NCI (National Cancer Institute) and key universities, to strategically accelerate the development of novel drug leads in the therapeutic areas of cancer, infectious diseases, inflammation and neurological disorders. Biosortia Pharmaceuticals has seen promising early results with dozens of novel compounds having already been requested, and are under evaluation with NCI and Eli Lilly.

Dieck has spent nearly 30 years in healthcare, including 18 years at Arthur Andersen as a global equity partner and then 10 years with Cardinal Health, a Fortune 20 public company, as a senior executive; there he worked with a broad spectrum of partners, including brand pharmaceutical manufacturers, throughout the supply chain. Dr. Guy Carter has over 30 years of experience working in pharmaceutical R&D, primarily in the discovery and development of microbial natural products. He previously was the leader of natural products drug discovery at Wyeth Research, as head of the Chemical Technologies Department.

“Kurt and Guy make a great team. Their complementary Pharma experiences and backgrounds create great opportunities to accelerate Biosortia’s objective to become the premier, aquatic natural products company with a primary focus in drug discovery,” says Ross Youngs, Biosortia’s Founder and Chairman. “Kurt and Guy bring a wealth of research and business experience along with deep industry relationships in building successful Pharma partnerships. Everyone involved with this young biotech is excited about the future.”

Industry observers have commented that late-stage R&D pipelines are not providing Pharma with the desired revenue growth the market is expecting. Therefore, large Pharma is evolving the way it performs R&D in order to optimize efficiency and to boost patent cliff defenses. These changes require shifting from relying solely on in-house chemistry-based R&D to acquiring and licensing external technologies and natural products based compounds in various stages of development. Biosortia’s ability to supply novel, highly active and potent compounds with drug-like characteristics will increase the productivity and success rate for Pharma as well as reduce the overall cost of the discovery process. The cost to discover, develop and launch a new drug is estimated to reach nearly $3B per drug by 2015. Biosortia’s business model is designed specifically to support Pharma’s needs.

“With nearly unlimited microorganisms (3.7 nonillion), the aquatic environment and its consortia represent an extraordinary opportunity…a new frontier, to access extremely potent and chemically diverse secondary metabolites with drug-like properties with unique mechanisms of action never researched before,” said Dieck. In describing the opportunity, Dieck goes on to say, “Biosortia is on the cutting edge of natural product discovery
and has the capabilities to deliver on its aspiration. Our powerful natural products research team, led by Dr. Guy Carter, in partnership with NOAA’s Dr. Peter Moeller, a leader in aquatic natural products research, has the experience and know-how to decipher the complex unexplored environment in a very efficient manner leveraging all the current state of the art instrumentation. The need for more efficient and effective approaches to drug discovery has never been more important. Biosortia’s innovative technologies, deep research skills and key relationships will efficiently provide thousands of unique natural products as candidates for drug discovery at a time when Pharma is in critical need for “high quality shots on goal.”

“Aquatic microbial consortia are a rich source of metabolically active organisms including microalgae, bacteria, fungi and their secondary metabolites,” states Carter. “Owing to the competitive nature of their habitat, chemical investigations of microbial consortia reveal unique structurally diversified natural products that are responsible for signaling and self-defense that have potential as therapeutics with novel mechanisms of action. Since they have been pre-optimized by nature, these compounds are typically closer to a drug candidate than a synthetic lead, thus requiring less optimization and shorter time when found as ‘hits’ in screening programs.”

The team has also focused on agreements with strategic collaboration partners as vital components to the strategy. Biosortia has recently entered into several collaboration agreements with NOAA, Analyticon and exclusive harvesting relationships, just to name a few. Several others will be advanced by the end of January. Biosortia’s cooperative research and development agreement (CRADA) with NOAA’s Center for Human Health Risk at Hollings Marine Laboratory provides a 5-year framework for research and development regarding the analysis and purification of novel bioactive compounds. According to NOAA’s Technology Partnerships Office, “Success will result in the commercial development of new and unique chemical compounds from the sea which have benefits to human health, either through disease prevention or new treatments for disease.”

Dr. Peter Moeller, NOAA’s Research Scientist who leads the Toxins Natural Products Program stated after analyzing fractions of Biosortia’s biomass, “Coupling NOAA’s mission of characterizing toxins affecting environmental and/or human health with Biosortia’s drug discovery focus turns one man’s toxin into another’s chemotherapeutic. The microorganisms analyzed in the Biosortia biomass identified more unique activity than I have seen in my 30 year career. The volumes achieved from a single harvest delivered an equivalent of 30 years of accumulation. This could materially change the landscape for natural products drug discovery research.”

As of December 31, 2012, Biosortia has identified more than 30 bioactive candidate compounds (hits) from a fresh water eutrophic lake consortium. Therapeutic areas of focus include treatments for cancer, infectious diseases, inflammation and neurological disorders. In addition, more than a dozen of its patent protected compounds are in initial evaluation stage within Eli Lilly’s Open Innovation Drug Discovery Program.

Dieck states, “Looking forward, it is with great optimism. We have a great team built around mutual respect, deep experience, and a desire to succeed and make a difference. We are aligning with the right partners and collaborators to execute our strategy with speed and discipline to provide Pharma with much high quality & diverse compounds vs. “me-too” drugs than they have had in the past 10 years. We are excited about what this company can accomplish, not only for its shareholders but also for the millions of people who have been diagnosed with various forms of chronic diseases who are looking for Pharma to identify better ways to help them extend their lives or live a more productive life. Biosortia can play a big role in identifying compounds that can help Pharma achieve these goals. I am looking forward to the challenge and opportunity to build an industry leading drug discovery company.”

Via EPR Network
More Healthcare press releases

EMS Healthcare forges ahead with new mobile cancer unit

EMS Healthcare is helping The Clatterbridge Cancer Centre deliver care closer to the community with the development of a bespoke mobile chemotherapy unit.

Clatterbridge in the Community will take to the road from early January, delivering treatment to patients at the Sealand Tesco site as a pilot prior to a roll out across Chester and the Wirral, using its fully customised mobile medical unit to reduce unnecessary stress from travel and help to cut down waiting times.

Keith Austin, Managing Partner in EMS-Healthcare said: “We have been working closely with The Clatterbridge Cancer Centre to develop a mobile facility that will ensure they can deliver first class patient care close to people’s homes, right in the heart of the community. The medical vehicle has been designed specially to meet their requirements and we anticipate that it will house the largest mobile chemotherapy treatment space in the country.”

The Clatterbridge Cancer Centre is one of the largest networked cancer centres in the UK. From nine operating sites across Merseyside and Cheshire it treats over 27,000 patients a year, offering pioneering chemotherapy, radiotherapy and proton therapy treatments.

Kim Barrow, Head of Daycase and Outpatient Services at The Clatterbridge Cancer Centre said: “Over the last few months EMS Healthcare has been working hard to turn our vision into reality. We are delighted with the progress and look forward to launching the new care unit to patients in the New Year.”

EMS-Healthcare’s work with The Clatterbridge Cancer Centre follows a successful health roadshow campaign delivered on behalf of cancer charity, Tenovus, which treated 15 chemo patients per day in South Wales. This mobile medical unit was the first of its kind in the UK.

Via EPR Network
More Healthcare press releases

Sprint Bioscience Strengthens Its Cancer Metabolism Portfolio

Sprint Bioscience, a Swedish company developing oncology therapeutics targeting cancer metabolism, announced today that it has raised money to strengthen its drug discovery portfolio.

The investment by Första Entreprenörsfonden and Almi Invest will enable the company to continue to build a pipeline of drug discovery projects within cancer metabolism.

“We are investing in Sprint Bioscience because we consider their entrepreneurial drive and their particular skills in drug development to be key success factors for the changing environment of the future pharmaceutical industry. Sprint Bioscience’s business strategy involves out-licensing or collaborating at an early stage of drug discovery to ensure that projects are developed with a focus on current and relevant market needs,” says Rune Nordlander, partner at Första Entreprenörsfonden.

Sprint Bioscience is a company founded by experienced drug hunters with an ambition to improve the drug discovery process. “We believe in small organisations with effective working procedures and collaborations throughout the sector,” says the company’s CEO and co-founder, Dr. Anders Åberg.

“Sprint Bioscience has developed an efficient, fragment-based drug discovery (FBDD) platform that can take parallel projects from initial idea to active molecules tested in cell-based systems in a very short time” Anders Åberg continues. Our goal is to align the early phase in the laboratory with pharmaceutical companies’ needs.

Targeting the metabolism in tumours provides exciting opportunities to develop drug therapies with novel mechanisms of action. This could be used to overcome the resistance that many cancer cells develop to current treatments.

Via EPR Network
More Healthcare press releases

Coalition For The Advancement Of Brachytherapy

The Coalition for the Advancement of Brachytherapy (CAB) has reviewed recent media reports stemming from a study originally presented in December 2011 by physicians associated with the University of Texas MD Anderson Cancer Center. The study compared the efficacy of whole breast irradiation (WBI) to accelerated partial breast irradiation (APBI), including the use of brachytherapy to treat select patients with early stage breast cancer. CAB believes that the methodology used in the MD Anderson study is misleading as it utilizes a Medicare billing claims database that does not include patient risk stratification data and therefore is not appropriate to use to compare outcomes and toxicities of ABPI to that of whole breast irradiation (WBI).

The treatments examined utilize different methodologies for delivering radiation therapy following surgery for the treatment of breast cancer. APBI delivers a targeted radiation therapy to select low risk patients over a five-day period. Whereas WBI delivers a broader radiation therapy whereby the entire breast is treated over the course of 30-40 days. The conclusions reached regarding the relative efficacy of the two forms of treatments are based completely on a retrospective study of insurance billing claims. This retrospective study fails to take into account key patient clinical characteristics, including, but not limited to pathology and staging, which determine risk assignment of a patient. Further, the billing code data was collected from patients treated from 2000 through 2007. Since that time, advances in brachytherapy product design, physics planning and delivery of dose have led to greater precision and accuracy of radiation treatment with improved outcomes.

CAB contends that it is impossible to draw any meaningful comparisons or conclusions without taking into consideration patient risk assessments. Counter to the findings in the MD Anderson study are multiple peer-reviewed publications available supporting the safe and effective use of APBI in appropriately selected patients. The safety and effectiveness of APBI is further supported by the fact that the American Society of Radiation Oncology (ASTRO) reaffirmed its Consensus Statement in 2011 endorsing the use of APBI in appropriately selected patients. The ASTRO APBI Consensus Statement was originally issued in 2009 based on an exhaustive search of the available medical literature in combination with expert opinion and public comment.

More recent data from a trial comprising over fourteen hundred breast cancer patients, presented on May 5, 2012 at the American Society of Breast Surgeons (ASBrS) Annual Meeting, found that APBI is equally effective, if not more effective, in preventing local breast cancer recurrence than WBI. * This trial’s findings not only contradict the MD Anderson data in finding that tumor control in the breast appears to be similar for APBI and WBI, but suggest that disease control at the initial tumor site may be better with APBI.

Michael Krachon, CAB Chair notes, “The MD Anderson study is by no means sufficient to condemn a promising procedure like APBI brachytherapy. As we await results of the randomized NSABP-B39 Phase III Trial comparing WBI to APBI, physicians should be mindful of the many positive peer-reviewed publications analyzing the efficacy and toxicity associated 2 1455 Pennsylvania Ave. NW, Suite 250, Washington, D.C. 20004 with APBI brachytherapy. The technique has been endorsed by ASTRO in appropriately selected patients, and physicians must take into account the clinical presentation of the patient and their own clinical judgment in the safe and appropriate use of this treatment modality.”

For more information contact: Richard White, Roberti + White at (202) 624-0395

Via EPR Network
More Healthcare press releases

Quoteboffin.co.uk Urges Health Providers To Maintain Momentum In Light Of Improving Cancer Survival Rates

Survival rates for some cancers has doubled since the 1970s. Now health and life insurance comparison site, QuoteBoffin.co.uk, is calling on health organisations to continue their good work.

Following research by leading organisation Cancer Research UK, it has emerged that survival rates for some cancers including bowel, breast and ovarian have doubled over the past four decades.

Comparisons between survival rates for those with cancer in the 1970s and people with the disease in the late noughties show vast improvements in the number of patients expected live more than ten years with the disease.

Breast and bowel cancer have seen remarkable improvements in survival rates with the number of people living at least ten after diagnosis years jumping from 40% to 77% and 23% to over 50% respectively.

Despite the improvements, health organisations and cancer charities are still calling for more work to be done to improve cancer patients chances of survival.

A spokesperson from QuoteBoffin.co.uk joined the calls for further research, with cancer treating drugs high on the agenda:

“It’s encouraging to see such a stark improvement in cancer survival rates in such a short space of time.

“As technology improves so does our ability to detect and treat cancer earlier and earlier and this brings with it its own set of problems.

“No longer is cancer treatment about prolonging a patient’s life, it’s about completely curing the disease altogether so now we must put more and more money and time into crafting and fine tuning a range of drugs and treatments that can be applied to the disease at any stage.”

Via EPR Network
More Healthcare press releases

Training To Cut Medical Prejudice For Obesity Essential, Says Life Insurance Comparison Site Quoteboffin.co.uk

Insurance comparison site Quoteboffin is among those calling for the introduction of training to minimise prejudice towards obese patients.

Obesity is a huge problem in the UK and one that’s on the rise. The fact that the condition is costing the NHS money time and resources every year is widely documented in the media and this can lead to prejudice towards people living with the condition.

Past research has found that this prejudice can also be found amongst medical health care professionals. However, a recent study from the Obesity Journal has found that training can easily influence this attitude.

A spokesperson from Quoteboffin, a life insurance comparison site, announced that the company was among those backing the journal’s calls for implementing the training. They added: “Sometimes people don’t even realise they have a prejudice and they think they are working impartially, however when their actions are looked at more closely, a different picture emerges.

“It’s important that all people receive the medical car, compassion and attention they need no matter what their conditions.”

Via EPR Network
More Healthcare press releases

Quoteboffin.co.uk Encourages Women To Take Vitamin And Calcium Supplements To Cut Breast Cancer Risk

Vitamin supplements have been in for a hard time in recent years, with some health professionals claiming they have little effect on overall health. However, a new study has found that vitamin and calcium supplements could help women cut their risk of breast cancer by up to a third.

Quoteboffin.co.uk Encourages Women To Take Vitamin And Calcium Supplements To Cut Breast Cancer Risk

The research, which examined the diet and health of 700 women, found that those with nutrients added to their diet were up to 40 per cent less likely to develop breast cancer. In a report from the Scotsman, lead researcher of the study, Professor Jaime Matta, made it clear that it wasn’t a case of immediate protection, but rather a long-term effect.

Health insurance site Quoteboffin.co.uk has stated its hope that the study will prompt an uptake in the consumption of vitamin and calcium supplements in women across the country. A spokesperson explained: “Breast cancer can be a devastating illness for sufferers and it’s very encouraging to hear news of this study from the Ponce School of Medicine in Puerto Rico.

“If a simple supplement can help women cut the risk of them developing breast cancer in the future then we strongly advise they think seriously about it.”

The study analysed 268 women with breast cancer and 457 healthy controls and discovered that vitamin supplements could cut the risk of breast cancer by up to 30 per cent, and that the danger could be cut by up to 40 per cent when combined with calcium supplements.

Via EPR Network
More Healthcare press releases

LighterLife Launches Listen And Learn Podcast Service

LighterLife, the industry leading weight loss and weight-management company, has released the first of a series of monthly podcasts, designed to help people learn how to live healthier, lighter lives.

Titled ‘Inside LighterLife’, this is the place to listen to tips, advice and features on how to lose weight quickly and safely, as well as interviews with health experts, LighterLife Weight-Management Counsellors and real-life people who have struggled with their weight.

Unscripted, conversational and honest – like a morning TV chat show on the run – the first podcast sees host Susan Spence, a multi-skilled presenter who can also be heard on LBC, Radio Five Live and the Steve Allen Show chatting to Dr Hilary Jones about some pressing weight-related medical questions, talking to LighterLife Weight-Management Counsellor Lindsey Thompson-Wright from Loughton, Essex about the stories behind the weight loss of some of her clients and meeting with Rachel Drago, an inspirational client who tells why she believes LighterLife literally saved her life.

Rachel Drago hit the headlines a few months ago after losing five stone with LighterLife and losing 10 inches of fat off her breasts allowed her to discover a lump in her breast that was subsequently diagnosed as breast cancer. Plus listeners will be able to hear how 12 overweight men’s 52 stone weight loss with LighterLife gave them the confidence to strip naked and bare all to raise money for The Prostate Cancer Charity.

Upcoming episodes of the new weight loss podcast, Inside LighterLife, will include further expert advice from Psychotherapist Annie Wilson who will discuss some of the psychological reasons behind overeating, more inspirational weight-loss stories and advice and encouragement for overweight and obese people to lose weight and maintain a healthy lifestyle.

Available to download free from iTunes, podcast directories and the LighterLife website, Inside LighterLife gives clients the opportunity to listen to and identify with the experiences of others on the programme. For many clients it will offer a motivational boost and for others it will provide the support they need when they are having a weak moment.

As well as allowing clients to listen and learn more about LighterLife, Inside LighterLife also offers potential clients an inside look into a programme that has helped 150,000 people lose weight and keep it off.

Sara Jamison, CEO, LighterLife commented: “Inside LighterLife is another fantastic additional service that we are offering to both LighterLife clients and all those people out there who have struggled with their weight or who are losing weight using other methods. Listeners will be able to learn more about LighterLife from the people who have actually lived, breathed and succeeded on it, have their questions answered by the experts and listen to tips and advice that will help them live lighter, happier lives and we can’t wait to hear the feedback.”

Via EPR Network
More Healthcare press releases

LighterLife Has Produced A Brand New Calendar To Help Raise Money For The Prostate Cancer Charity

LighterLife has produced a brand new calendar to help raise money for the Prostate Cancer Charity. The calendar features 12 men who have lost weight with LighterLife baring all for the cameras.

These brave men, from various walks of life had a variety of personal reasons for losing weight which ranged from being able to keep up their kids and reducing the risk of bad health, through to wanting to apply to become a fireman. What brought these men together was that they all had the same goal; to lose weight with LighterLife. With their lives changed for the better, they stripped down to not only celebrate their amazing weight loss, but to also raise money and awareness for a charity close to their hearts.

Lee, who posed for the month of January, lost six stone and is now running rings around his young football team. Gary, otherwise known as Mr. February, is six stone lighter and no longer lags behind the rest of his walking group. Lee, or Mr. March, has lost the five stone he put on after being diagnosed with testicular cancer.

Mark, who can be seen in the calendar in April, has a new lease on life and can keep up with his kids after losing four stone. Mike, or Mr. May, is no longer clinically obese and since losing just under three stone, is a faster and more confident water polo player. Five stone lighter, Nuno, or Mr. June, now has the confidence and the BMI to apply for his dream job as a fireman.

Former yo-yo dieter Phil, who posed for July, lost three stone which has given him the confidence to do what he loves – DJ’ing. Steven, or Mr. August, can now enjoy a full game of football without feeling tired and Rod, who features in September, is now training for a triathalon to help maintain his five stone weight loss.

LighterLife weight-management Counsellor Gina Lennon, who coordinated the men during the calendar photo shoot, said: “I’m delighted to have been involved in this project. There has been a great deal of interest and this has definitely put the fun back into fundraising. The calendar boys have achieved so much – losing such large amounts of weight, maintaining their weight loss, overcoming fears about their body image and baring all to raise money for a very worthwhile charity.”

Via EPR Network
More Healthcare press releases

International Masters Publishers, Inc., On Behalf Of Its Collection Of Health And Well-Being Products Has Made A Donation To Rocking The Road For A Cure, Inc.

International Masters Publishers, Inc., on behalf of its collection of Health and Well-being products has made a donation to “Rocking the Road for a Cure, Inc.” — a non-profit organization founded to provide free education and support services for women and men going through the diagnosis and treatment of breast cancer.

Reflecting their strong commitment to providing valuable health information, International Masters Publishers, Inc. (IMP) recently announced its continuing support for breast cancer research and wellness programs through its contribution to the community-based non-profit organization “Rocking the Road for a Cure, Inc.”

Founded by Dawn Frey after she was diagnosed with breast cancer, “Rocking the Road for a Cure, Inc” provides free support services aimed to enhance the coping skills of those in treatment, and expand the support networks that have proven so essential to their quality of life. These services include:

• Homebound Yoga, Reiki and massage
• Medical case management assistance
• Homebound Recreational Therapy
• Beauty consultations
• Nutrition advice and services

“We are proud to support the great work done by Rocking on the Road for a Cure, Inc.”, says Dilenia Chireno, IMP Spokesperson, “their programs use many of the same approaches to self-empowerment we cover in our collections, so it’s really an excellent fit for us. We are so proud to be part of this important and worthwhile cause.”

In addition to its generous corporate donation, IMP will also offer some customers of The Complete Guide to Natural Healing and Enhancing Your Mind Body Spirit the opportunity to make an additional donation by contributing a portion of the proceeds it receives from these two products to this great cause.

Via EPR Network
More Healthcare press releases

The Facts About Heart Disease

  • Heart Disease has been the number 1 killer in the US every year since 1900 with the exception of 1918.

  • At least 250,000 Americans die of heart attacks each year before they reach the hospital.

  • Every 34 seconds someone in the US dies from Heart Disease.

  • Heart Disease can be avoided with good nutrition.
If you are as little as 10 pounds overweight you are at risk forHeart Disease.Chronic Diseases cost the US economy 1.3 trillion dollars annually and this could reach 6 trillion by the middle of the century.

Reduce the Risk of Heart Disease for you and your loved ones. Over and over again I hear success stories of how people who have used our science based, nutritional products to lose weight. But not only do they lose weight but they are lowering their cholesterol levels, stabilizing blood pressure and sugar levels and are getting off of medications they have been taking for years. We have had people say they have gotten rid of allergies, migraines, joint pain and more. Good Nutrition allows your body to heal. (individual results vary). You can gain weight, lose weight, or maintain weight with our products. Our products do come with a guarantee.

My mother and father have both had open heart surgery. It is not a fun thing to go through. The thought of having your breast bone broken in half and raised in vertical position for hours is not a pretty picture to me. I do not wish to ever need this surgery and I am here to help you, in hopes that you do not ever need it as well.

Good Nutrition affects everything:

  • health

  • energy

  • organs

  • cells

  • vitality

  • skin

  • quality of life

The American Medical Association has said that 70% of medical conditions are diet related.

Here are a few common diseases that may be prevented with proper diet and or maintaining a healthy weight.

Cancer: breast, uterus, cervix, colon, esophagus, pancreas, kidney and prostrate
Coronary Heart Disease, Diabetes, Dyslipidemia, hypertension
Idiopathic Intacraial hypertension, stroke, cataracts
Osteoarthritis, skin, gout, phlebitis
Gynecologic Abnormalities, abnormal menses,infertility, poly cystic ovarian syndrome
Gall Bladder Disease
Pulmonary Disease
Obstructive Sleep Apnea
Hypo ventilation Syndrome
Severe Pancreatitis
Non Alcoholic Fatty Liver Disease

If you truly want to feel good and enjoy quality of life you need to get started with Core Nutrition. Once you receive your Core Nutrition, I will send you a personalize your program DVD (FREE), I will give you personalized coaching on a regular basis (FREE) to help you achieve your wellness goals, and you will receive a FREE Wellness Evaluation. A Wellness Evaluation will help you learn better dieting habits as well as give you a better understanding about where you are at with your health and wellness. We will be able to determine what your goals are and come up with some recommendations that will help you be able to enjoy a better quality of life.

Once you get started with our Core Nutrition or Weight Loss Program you may find that you are saving money on your prescriptions plus doctor and hospital bills. You may even be earning more money because you are missing work less and are able to work longer hours.

Via EPR Network
More Healthcare press releases

Field Fisher Waterhouse has recovered compensation for the cost of a claimant’s hospice care in a case that is though to be the first of its kind

Field Fisher Waterhouse (FFW), the full service European law firm, has recovered the value of the hospice care that was required by a claimant. This is thought to be the first case of its kind, with most hospices generally exclusively funded by charitable donations. As part of the settlement, the firm was able to recover £12,500 to be paid over to the hospice.

The case arose out of the death of a 64 year old man due to mesothelioma, an asbestos-related cancer, in December 2007 after spending his final days being cared for in a North London Hospice dedicated to cancer patients.

Through his life the man suffering from the cancer had worked as a carpenter, painter and labourer. In 1963, whilst employed as a painter for J Murphy & Sons Ltd, he was exposed to asbestos dust whilst sanding down and filling in walls in prefabricated housing containing asbestos. He was then exposed to further asbestos when working for the same company at a factory in Dagenham, cleaning debris from the guttering on roofs made from corrugated asbestos.

In August 2005 he was diagnosed with mesothelioma, an asbestos related cancer on the lining of one of his lungs. He was eventually admitted to the hospice where he spent the last month of his life.

Rodney Nelson-Jones, partner in the Asbestos Claims Group at Field Fisher Waterhouse, was instructed to claim compensation on behalf of the man’s family. The firm was able to recover £170,000 from J Murphy & Sons Ltd, £12,500 of which is being paid to the hospice which provided him with care worth over £400 a day.

This is thought to be the first time that compensation has been recovered for a patient’s hospice care, which is usually funded by charitable donations. It has long been possible to recover compensation for the value of care provided by relatives but FFW’s innovation has been to extend this principle to charitable care provided by hospices. The firm plans to continue to claim the cost of hospice care in future mesothelioma cases.

Rodney Nelson-Jones commented: “We are delighted to have been able to secure extra funding for the hospice. Hospices do a wonderful job and rely on charitable donations to provide much needed palliative care for cancer patients. We hope that this case will mean that they are now provided with an additional source of funding.”

About Field Fisher Waterhouse
Field Fisher Waterhouse LLP is a full-service European law firm with offices in Brussels, Hamburg and London. With 119 partners, over 200 other lawyers and nearly 300 support staff, FFW assist a wide range of international clients, advising across a full range of legal issues.

The main areas of practice are corporate and commercial, IP and technology, banking and finance, regulatory and real estate. Field Fisher Waterhouse LLP also have particular expertise in competition & EU law, dispute resolution, employment, asbestos and mesothelioma claims, personal injury cases and clinical negligence, public sector and tax.

Via EPR Network
More Healthcare press releases

“2008 Breaking Boards For Breast Cancer” At Waterfire In Providence To Support The Gloria Gemma Breast Cancer Foundation

In recognition of Breast Cancer Awareness Month, Mastery Martial Arts will sponsor a fundraising event to “break boards” on October 11, 2008. Join a community of supporters at the Waterfire of Providence event to benefit people living with breast cancer.

Mr. Greg Horton, founder of Mastery Martial Arts will have his black belt instructors demonstrate the breaking of boards in rapid fire succession in the exhilarating celebration and symbolic ritual of empowering women to harness the fight. The broken boards will be placed in the Waterfire brassieres while you watch your special message and wishes become spiritually delivered through the tranquil burning of this special WaterFire of Providence celebration.

In a dramatic ending, over 300 torch bearers will unite and illuminate the Rhode Island state house in pink to show the dedication and strength in fighting for a cure.

Donations can be made by purchasing a board ($5.00) or a block of wood ($50.00), or a simple donation complimented by a personal message or wish for someone suffering from breast cancer. The funds raised will go to the Gloria Gemma Breast Cancer Foundation to support breast cancer awareness and generate funding for critical breast health programs.

Visit http://www.firstgiving.com/bonitaboutin/ to make your donation today.

About Us:
Bonita Boutin, the Rhode Island organic skin care impresario understood early on how she could motivate and inspire women to celebrate life and achieve strength from within. Because of her personal family experiences with breast cancer, Bonita Boutin is dedicated to providing breast cancer support and awareness to women throughout the world.

Bonita Boutin founded Bonita Botanicals Skin Care in Rhode Island to holistically raise the quality of life for adults and students through organic and natural living. In addition to martial arts being enjoyable and satisfying Bonita equates the sport as being a confidence booster and a way to advocate and inspire women to harness the power to fight. She is particularly dedicated to helping fight breast cancer and celebrate life in Providence RI.

Visit Bonita’s breast cancer blog at www.breastcancernews.brighterplanet.org and get inspired to join a passage in seeking answers and finding a cure.

Via EPR Network
More Healthcare press releases